Adrenomedullin and adrenomedullin binding protein-1 protect endothelium-dependent vascular relaxation in sepsis

Molecular Medicine

Volumn 13, Issue 9-10, 2007, Pages 488-494

  Zhou, Mian ^a   Maitra, Subir R ^a   Wang, Ping ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN BINDING PROTEIN 1; BINDING PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; MALE; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; THORACIC AORTA; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

ACETYLCHOLINE; ADRENOMEDULLIN; ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; MALE; NITRIC OXIDE SYNTHASE TYPE III; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; VASODILATION; VASODILATOR AGENTS;

EID: 35348820037     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00113.Zhou     Document Type: Article

References (55)

1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
2. Martin GS, Mannino DM, Eaton S, Moss M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-54.
3. Hotchkiss RS, Karl IE. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-50.
4. Tracey KJ. (2002) The inflammatory reflex. Nature 420:853-9.
5. Riedemann NC, Guo RF, Ward PA. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9:517-24.
6. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-10.
7. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-60.
8. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. (1993) Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:921-7.
9. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. (1996) Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J. Clin. Endocrinol. Metab. 81:1449-53.
10. Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, Miyamoto S, Dohi K, Minamino N, Shoji H, Kitamura K, Kangawa K, Matsuo H. (1997) Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit. Care Med. 25:953-7.
11. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. (1997) High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp. Clin. Endocrinol. Diabetes 105:156-62.
12. Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, Doi N, Murao Y, Miyamoto S. (1999) Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am. J. Respir. Crit. Care Med. 160:132-6.
13. Fujioka S. (2001) Increased plasma concentration of adrenomedullin during and after major surgery. Surg. Today 31:575-9.
14. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsio H. (1995) Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 207:25-32.
15. Shoji H, Minamina N, Kangawa K, Matsuo H. (1995) Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem. Biophys. Res. Commun. 215:531-7.
16. Ono Y, Kojima M, Okada K, Kangawa K. (1998) cDNA cloning of canine adrenomedullin and its gene expression in the heart and blood vessels in endotoxin shock. Shock 10:243-7.
17. Zaks-Zilberman M, Salkowski CA, Elsasser T, Cuttitta F, Vogel SN. (1998) Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (taxol) in murine macrophages. Infect. Immun. 66:4669-75.
18. Elsasser TH, Sartin JL, Martinez A, Kahl S, Montuenga L, Pio R, Fayer R, Miller MJ, Cuttitta F. (1999) Underlying disease stress augments plasma and tissue adrenomedullin (AM) responses to endotoxin: colocalized increases in AM and inducible nitric oxide synthase within pancreatic islets. Endocrinol. 140:5402-11.
19. Matsui E, Kitamura K, Yoshida M, Kato J, Asada Y, Sumiyoshi A, Eto T. (2001) Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens. Res. 24:543-9.
20. Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. (1998) Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J. Cardiovasc. Pharmacol. 31 (Suppl 1):S541-4.
21. Zhou M, Chaudry IH, Wang P. (2001) The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R654-60.
22. Elsasser TH, Kahl S, Martinez A, Montuenga LM, Pio R, Cuttitta F. (1999) Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinol. 140:4908-11.
23. Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, Elsasser TH, Cuttitta F. (2001) Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276:12292-300.
24. Friese MA, Hellwage J, Jokiranta TS, Meri S, Peter HH, Eibel H, Zipfel PF. (1999) FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol. 36:809-18.
25. Schwaeble W, Zwirner J, Schulz TF, Linke RP, Dierich MP, Weiss EH. (1987) Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur. J. Immunol. 17:1485-9.
26. Luo W, Vik DP. (1999) Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand. J. Immunol. 49:487-94.
27. Schwaeble W, Schwaiger H, Brooimans RA, Barbieri A, Most J, Hirsch-Kauffmann M, Tiefenthaler M, Lappin DF, Daha MR, Whaley K. (1991) Human complement factor H. Tissue specificity in the expression of three different mRNA species. Eur. J. Biochem. 198:399-404.
28. Zhou M, Ba ZF, Chaudry IH, Wang P. (2002) Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283:R553-60.
29. Yang S, Zhou M, Fowler DE, Wang P. (2002) Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: Down-regulation of proinflammatory cytokines. Crit. Care Med. 30:2729-35.
30. Yang S, Zhou M, Chaudry IH, Wang P. (2002) Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann. Surg. 236:625-33.
31. Zhou M, Simms HH, Wang P. (2004) Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann. Surg. 240:321-30.
32. Wang W, Mitra A, Poole B, Falk S, Lucia MS, Tayal S, Schrier R. (2004) Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am. J. Physiol. Renal Physiol. 287:F1044-8.
33. Zhou M, Wang P, Chaudry IH. (1997) Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim. Biophys. Acta. 1335:182-90.
34. Wang P, Ba ZF, Chaudry IH. (1994) Nitric oxide: to block or enhance its production during sepsis? Arch. Surg. 129:1137-43.
35. Wang P, Chaudry IH. (1998) A single hit model of polymicrobial sepsis: cecal ligation and puncture. Sepsis 2:227-33.
36. Yang S, Cioffi WG, Bland KI, Chaudry IH, Wang P (1999) Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis. J. Trauma 47:706-12.
37. Wang P, Zhou M, Ba Z., Cioffi WG, Chaudry IH (1998) Upregulation of a novel potent vasodilatory peptide adrenomedullin during polymicrobial sepsis. Shock 10:118-23.
38. Wang P, Yoo P, Zhou M, Cioffi, WG, Ba ZF, Chaudry IH. (1999) Reduction in vascular responsiveness to adrenomedullin during sepsis. J. Surg. Res. 85:59-66.
39. Koo DJ, Zhou M, Chaudry IH, Wang P (2001) The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J. Surg. Res. 95:207-18.
40. Koo DJ, Yoo P, Cioffi WG, Bland KI, Chaudry IH, Wang P (2000) Mechanism of beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J. Surg. Res. 91:70-5.
41. Kaomi H, Kanazawa H, Hirata K, Kurihara N, Yano Y, Otano S. (1995) Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. 211:1031-5.
42. Isumi Y, Kubo A, Katafuchi T, Kangawa K, Minamir N. (1999) Adrenomedullin suppresses interleukin-l_-induced tumor necrosis factor-α production in Swiss 3T3 cells. FEBS Lett. 463:110-6.
43. Koo DJ, Chaudry IH, Wang P. (1999) Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J. Surg. Res. 83:151-7.
44. Wu R, Zhou M, Wang P. (2003) Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regulatory Pept. 112:19-26.
45. Wang P, Ba ZF, Chaudry IH. (1995) Endothelium dependent relaxation is depressed at the macroand microcirculatory levels during sepsis. Am. J. Physiol. 269:R988-93.
46. Equchi S, Hirata Y, Iwanski H, Sato K, Watanabe TX, Inui P, Nakajima K, Sakakibara S, Marumo F. (1994) Structure activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135:2454-8.
47. Montuenga LM, Martinez A, Miller MA, Unsworth EJ, Cuttitta F. (1997) Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology 138:440-51.
48. 2+ mobilization in bovine aortic endothelial cells. J. Biol. Chem. 270:P4412-7.
49. Hinson JP, Kapas S, Smith DM. (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21:138-67.
50. Nishimatsu H, Suzuki E, Nagata D, Mooiyama N, Satonaka H, Walsh K, Sata M, Kangawa K, Matsuo H, Gotto A, Kitamura T, Hirata Y. (2001) Adrenomedullin induces endothelium dependent vasorelaxation via the phosphatidylinositol 3-Kinase/Akt-dependent pathway in rat aorta. Circ. Res. 89:63-70.
51. Cui X, Wu R, Zhou M, Dong W, Ulloa L, Yang H, Wang H, Tracey KJ, Simms HH, Wang P. (2005) Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit. Care Med. 33:391-8.
52. Cui Y, Ji Y, Wu R, Zhou M, Wang P. (2006) Adrenomedullin binding protein-1 is downregulated during polymicrobial sepsis in the rat. Int. J. Mol. Med. 17:925-9.
53. Vallet B. (2003) Bench-to-bedside review: Endothelial cell dysfunction in sepsis: a role in organ dysfunction? Crit. Care 7:130-8.
54. Yamashita T, Kawashina S, Ohashi Y. (2000) Resistance to endotoxin shock in transgenic mice overexpressing nitric oxide synthase. Circulation 101:931-7.
55. Parker JL, Adams HR. (1993) Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ. Res. 72:539-51.